Prices are closing data as of 2026-11-09, not real-time quotes. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for Astera Labs, Inc.?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2022–2025
Key Multi-Year Facts
- Revenue moved from $79.9M in FY2022 to $852.5M in FY2025 (3-year CAGR +120.2%).
- Net income was negative in FY2022, FY2023, FY2024.
Latest 4 Fiscal Years
| Fiscal Year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue (USD B) | 0.08 | 0.12 | 0.40 | 0.85 |
| YoY | — | 45.0% | 242.2% | 115.1% |
| Net Income (USD B) | -0.06 | -0.03 | -0.08 | 0.22 |
| Operating Cash Flow (USD B) | -0.04 | -0.01 | 0.14 | 0.32 |
| ROE | — | — | -8.6% | 18.8% |
| Gross Margin | 73.5% | 68.9% | 76.4% | 75.7% |
| Net Margin | -73.0% | -22.7% | -21.1% | 25.7% |
| Debt-to-Assets | — | 19.8% | 8.5% | 11.0% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: SEC XBRL filings, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-10
Rules-based screening using SEC XBRL financial data and 8-K/NT material event filings (no AI opinions).
Checked across financial quality, solvency, going concern, and SEC material filings (bankruptcy, delisting notice, auditor change, non-reliance, late filing) with no alerts or watch items triggered.
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
More U.S. data: 500 largest U.S. companies · U.S. high dividend stocks · Is the stock market open today?
Compiled mechanically from public filings and market quotes (data as of 2026-11-10). For informational purposes only, not investment advice.